Abstract

Osteogenesis imperfecta (OI), a congenital bone disorder, is caused by mutations in COL1A1 and COL1A2 genes, leading to deficiency of type I collagen. The high resolution melting (HRM) analysis has been used for detecting mutations, polymorphisms and epigenetic alteration in double-stranded DNAs. This study was to evaluate the potential application of HRM analysis for identifying gene mutations in patients with OI. This study included four children with OI and their parents and fifty normal people as controls. Blood samples were collected for HRM analysis of PCR-amplified exons and flanking DNA sequences of COL1A1 and COL1A2 genes. Direct gene sequencing was performed to validate HRM-identified gene mutations. As compared to controls, HRM analysis of samples form children with OI showed abnormal melting curves in exons 11 and 33–34 of the COL1A1 gene and exons 19 and 48 of the COL1A2 gene, which indicates the presence of heterozygous mutations in COL1A1 and COL1A2 genes. In addition to two known mutations in the COL1A2 gene, c.982G > A and c.3197G > T, sequencing analysis identified two novel mutations in the COL1A1 gene, c.2321delC and c.768dupC mutations, which function as premature stop codons. These results support future studies of applying HRM analysis as a diagnostic approach for OI.

Highlights

  • Clinical examinations, including family and medical history and results from a physical exam, and radiological evidence provide major criteria for diagnosis of Osteogenesis imperfect (OI)

  • Since there are many mutations in COL1A1/ COL1A2 genes which are associated with OI and COL1A1/COL1A2 genes have many exons, genetic sequencing for OI diagnosis is time consuming and the cost is expensive

  • The aim of this study was to evaluate the potential use of High resolution melting (HRM) analysis for identifying mutations in the COL1A1/COL1A2 genes in patients with OI

Read more

Summary

Introduction

Clinical examinations, including family and medical history and results from a physical exam, and radiological evidence provide major criteria for diagnosis of OI. The aim of this study was to evaluate the potential use of HRM analysis for identifying mutations in the COL1A1/COL1A2 genes in patients with OI. We identified heterozygous mutations in COL1A1 and COL1A2 genes in children with OI using HRM analysis. Primers reported before for PCR amplification of COL1A1/COL1A2 genes with a size range of 80–260 bp (Supplemental Tables 1 and 2) were used.

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call